Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
New Zealand
/
Healthcare
Create a narrative
EBOS Group
NZSE:EBO Community
1
Narratives
written by author
0
Comments
on narratives written by author
29
Fair Values set
on narratives written by author
Create a narrative
EBOS Group
Popular
Undervalued
Overvalued
EBOS Group
WA
Analyst Price Target
Consensus Narrative from 9 Analysts
New High-Value Products And Expansion Into Southeast Asia Will Create Future Opportunities
Key Takeaways Strategic acquisitions and new high-value products in healthcare and animal care promise revenue and earnings growth. Cost efficiency measures and IT investments aim to improve margins and support organic growth.
View narrative
NZ$39.48
FV
1.2% undervalued
intrinsic discount
-0.51%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Your Valuation for
EBO
EBOS Group
Your Fair Value
NZ$
Current Price
NZ$39.00
18.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
15b
2015
2018
2021
2024
2025
2027
2030
Revenue AU$15.3b
Earnings AU$297.8m
Advanced
Set as Fair Value